La bourse est fermée

Medtronic plc (MDT)

NYSE - Nasdaq Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
124,84+0,69 (+0,56 %)
À partir de 12:25PM EDT. Marché ouvert.

Medtronic plc

20 On Hatch
Lower Hatch Street
Dublin 2
Ireland
353 1 438 1700
http://www.medtronic.com

Secteur(s)Healthcare
Secteur d’activitéMedical Devices
Employés à temps plein90 000

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Geoffrey Straub MarthaCEO & Chairman1,68MS.O.1970
Ms. Karen L. ParkhillExec. VP & CFO1,81MS.O.1965
Mr. Bradley E. LermanSr. VP, Gen. Counsel & Corp. Sec.1,74MS.O.1957
Mr. Mark PloofSr. VP of Global Operations and Bus. ServicesS.O.S.O.S.O.
Dr. Richard E. KuntzSr. VP & Chief Medical and Scientific OfficerS.O.S.O.1957
Mr. Sean LennonChief Information OfficerS.O.S.O.S.O.
Mr. Ryan WeispfenningVP of Investor RelationsS.O.S.O.S.O.
Ms. Marguerite CopelPR & Interim Chief Communications OfficerS.O.S.O.S.O.
Ms. Carol A. SurfaceSr. VP & Chief HR OfficerS.O.S.O.1966
Mr. Sean M. SalmonEVP, Pres of Diabetes Operating Unit & EVP & Pres of Cardiovascular PortfolioS.O.S.O.1966
Les montants ont été établis en date du 31 décembre 2020 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. The Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Minimally Invasive Therapies Group segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, hernia mechanical devices, mesh implants, and gynecology products; electrosurgical hardware and instruments, and mesh fixation devices; and gastrointestinal, inhalation therapy, and renal care solutions. The Restorative Therapies Group segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; colorectal surgeons; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Group segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Medtronic plc en date du 1 juin 2021 est 6. Les scores principaux sont Audit : 7; Société : 8; Droits des actionnaires : 6; Compensation : 4.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.